Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected more than 13,000 people in South Korea by July 2020. To prevent spread of COVID-19, tele-prescription was permitted temporarily. This study investigated the impact of tele-prescription on glycemic control in patients with type 2 diabetes. Methods: Glycated hemoglobin (HbA1c) concentrations were retrospectively analyzed in patients with type 2 diabetes who were treated with tele-prescription because of COVID-19 and those who were treated by face-to-face care (non-tele-prescription group) enrolled at the same period of time. Mean HbA1c concentrations and mean change in HbA1c concentration (ΔHbA1c) were compared in these two groups. Results: The mean HbA1c levels of patients were significantly higher after than before the tele-prescription period (7.46% ± 1.24% vs. 7.27% ± 1.13%, p < 0.05). Mean ΔHbA1c was significantly higher in the tele-prescription than in the non-tele-prescription group (0.19% ± 0.68% vs. 0.04% ± 0.95%, p < 0.05). HbA1c was significantly greater in patients taking fewer oral hypoglycemic agents, no insulin, fewer comorbidities (e.g., coronary artery disease, cerebrovascular accident, and diabetic neuropathy), and higher baseline HbA1c. Conclusions: Tele-prescription may worsen glycemic control in patients with type 2 diabetes during public health crises.
Abstract
Background/Aims: Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected more than 13,000 people in South Korea by July 2020. To prevent spread of COVID-19, tele-prescription was permitted temporarily. This study investigated the impact of tele-prescription on glycemic control in patients with type 2 diabetes. Methods: Glycated hemoglobin (HbA1c) concentrations were retrospectively analyzed in patients with type 2 diabetes who were treated with tele-prescription because of COVID-19 and those who were treated by face-to-face care (non-tele-prescription group) enrolled at the same period of time. Mean HbA1c concentrations and mean change in HbA1c concentration (ΔHbA1c) were compared in these two groups. Results: The mean HbA1c levels of patients were significantly higher after than before the tele-prescription period (7.46% ± 1.24% vs. 7.27% ± 1.13%, p < 0.05). Mean ΔHbA1c was significantly higher in the tele-prescription than in the non-tele-prescription group (0.19% ± 0.68% vs. 0.04% ± 0.95%, p < 0.05). HbA1c was significantly greater in patients taking fewer oral hypoglycemic agents, no insulin, fewer comorbidities (e.g., coronary artery disease, cerebrovascular accident, and diabetic neuropathy), and higher baseline HbA1c. Conclusions: Tele-prescription may worsen glycemic control in patients with type 2 diabetes during public health crises.
참고문헌 (18)
- Del Rio C, "COVID-19 : new insights on a rapidly changing epidemic", JAMA, 323, pp.1339~1340 (2020)
- "COVID-19" (2020)[URL]
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Liu H, "Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients : a systematic review and meta-analysis", Aging Dis, 11, pp.668~678 (2020)
- Kumar A, "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis", Diabetes Metab Syndr, 14, pp.535~545 (2020)
- Wootton R, "Recent advances : telemedicine", BMJ, 323, pp.557~560 (2001)
- Krumm M, "A review of contemporary tele-audiology literature", J Hear Sci, 6, pp.9~21 (2016)
- Lurie N, "The role of telehealth in the medical response to disasters", JAMA Intern Med, 178, pp.745~746 (2018)
- Garshnek V, "Applications of telemedicine and telecommunications to disaster medicine : historical and future perspectives", J Am Med Inform Assoc, 6, pp.26~37 (1999)
- Bian Y, "Artificial intelligence-assisted system in postoperative follow-up of orthopedic patients : exploratory quantitative and qualitative study", J Med Internet Res, 22, pp.e16896~ (2020)
- Piette JD, "The effect of automated calls with telephone nurse follow-up on patient-centered outcomes of diabetes care : a randomized, controlled trial", Med Care, 38, pp.218~230 (2000)
- Song X, "The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province", Crit Care, 24, pp.178~ (2020)
- "Rapid transition to a telemedicine service at Singapore community dialysis centers during COVID-19" (2020)[URL]
- Fisk M, "Telehealth in the context of COVID-19 : changing perspectives in Australia, the United Kingdom, and the United States", J Med Internet Res, 22, pp.e19264~ (2020)
- Zhai YK, "Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus : a systematic review and meta-analysis", Medicine (Baltimore), 93, pp.e312~ (2014)
- Timpel P, "Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension : an umbrella review of systematic reviews and meta-analyses", J Med Internet Res, 22, pp.e16791~ (2020)
- Flodgren G, "Interactive telemedicine : effects on professional practice and health care outcomes", Cochrane Database Syst Rev, (9), pp.CD002098~ (2015)
- Xu T, "Telemedicine in the management of type 1 diabetes", Prev Chronic Dis, 15, pp.E13~ (2018)